Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Major breakthrough in TB diagnosis
DNA
Scientists used genome techonology to isolate different strains of TB.
Scientists use genome sequencing to isolate strains of TB

Researchers in the UK have made a world-first breakthrough in the diagnosis of tuberculosis (TB).

According to BBC News, scientists at the Universities of Oxford and Birmingham have managed to isolate different strains of the disease using genome sequencing.

This means that patients will receive a diagnosis much faster, instead of waiting months for treatment.

Health secretary Jeremy Hunt said that the breakthrough "will save lives".

While incidents of TB in the UK have fallen in recent years, there are still some 6,000 cases reported each year. 

The illness is associated with health inequality, affecting people in deprived communities seven times more than people in the least deprived areas.

Scientists say they can identify the DNA strains in different samples in less than a week. As well as allowing patients to begin recovery sooner, this will also reduce the chance of infection spreading.

“We’re able to provide information on the species of organism and the drugs to which it may be resistant if it’s TB,” explained consultant microbiologist Dr Grace Smith.

This is the first time anyone in the world has applied genome technology on such a large scale, according to Public Health England.

The announcement comes as a new study shows that efforts to control the disease could be severely hampered by the rise in drug-resistant bacteria.

Published in The Lancet, the study found that one in five global cases of the disease is now resistant to at least one major treatment drug.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk